SCHEMBL9694231

SCHEMBL9694231

CCOC(=O)c1c2n(c3cc(N4CC[C@@H](NC(=O)C(F)(F)F)C4)c(F)cc3c1=O)C(C)S2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.47
PRKD3 O94806 1/20 0.43
PIM1 P11309 1/20 0.43
GSK3A P49840 1/20 0.43
GSK3B P49841 1/20 0.43
IRAK1 P51617 1/20 0.43
RPS6KA3 P51812 1/20 0.43
DYRK1A Q13627 1/20 0.43
PIM3 Q86V86 1/20 0.43
CSNK1G3 Q9Y6M4 1/20 0.43
KDM4E B2RXH2 5/20 0.42
ALDH1A1 P00352 5/20 0.42
HPGD P15428 2/20 0.42
HSD17B10 Q99714 2/20 0.42
TOP1 P11387 1/20 0.37
SMPD3 Q9NY59 1/20 0.35
GAA P10253 3/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
RAD52 P43351 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9693604 1.00 LMNA (0.47) LMNAPRKD3PIM1GSK3AGSK3B
SCHEMBL9693596 1.00 LMNA (0.47) LMNAPRKD3PIM1GSK3AGSK3B
SCHEMBL9692453 0.89 LMNA (0.47) LMNAPRKD3PIM1GSK3AGSK3B
SCHEMBL9692459 0.89 LMNA (0.47) LMNAPRKD3PIM1GSK3AGSK3B
SCHEMBL9694019 0.89 LMNA (0.47) LMNAPRKD3PIM1GSK3AGSK3B
SCHEMBL9692724 0.89 PIM1 (0.55) LMNAPRKD3PIM1GSK3AGSK3B
SCHEMBL9692738 0.89 PIM1 (0.55) LMNAPRKD3PIM1GSK3AGSK3B
SCHEMBL9731365 0.87 MTNR1A (0.37) LMNASMPD3MEN1KMT2A
SCHEMBL9692711 0.86 PIM1 (0.43) LMNAPIM1GSK3AGSK3BPIM3
SCHEMBL9694251 0.86 PIM1 (0.43) LMNAPIM1GSK3AGSK3BPIM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0465716-A1 Optically active thiazetoquino-line-3-carboxylic acid compound, method for preparation thereof, and a pharmaceutical composition comprising the same HOKURIKU PHARMACEUTICAL CO., LTD. (JP) 1992-01-15 EP disclosed